About this episode

Shashi Ramaiah discusses the challenges in drug development and how SPECCRO is leveraging new technologies to improve the process.

In this episode, Shashi Ramaiah discusses how outdated drug development practices and regulatory complexity can slow innovation and delay patient access to new therapies. He explains how SPECCRO combines traditional drug development expertise with emerging technologies such as AI, machine learning, organoids, and advanced in vitro models to improve decision-making, reduce risk, and accelerate development timelines. The conversation explores the challenges facing biotech startups, the importance of practical problem-solving, and how collaboration and new technologies are helping shape the future of medicine. Chapters: 00:00 The Challenge of Drug Development 04:00 Bridging Innovation and Regulation 08:43 Integrating New Approaches in Drug Development 12:28 The Role of Speccro in Drug Development 18:40 Building a Team and Client Relationships 23:23 Leveraging Technology and Data 28:18 Onboarding Clients and Problem Solving 31:28 Future Aspirations and Resilience in Startups Guest Information: Guest's Name: Shashi Ramaiah Guest's Title/Position: Founder & CEO LinkedIn: https://www.linkedin.com/in/shashi-ramaiah/ Company / Affiliation: SPECCRO https://speccro.com/ Guest's Bio…

People in this episode

Host: Heath Fletcher

Guest: Shashi Ramaiah

Topics covered

• drug development
• biotech startups
• innovation
• regulatory complexity
• emerging technologies
• collaboration
• future of medicine

Keywords

• drug development
• biotech
• AI
• machine learning
• innovation
• SPECCRO
• patient access
• therapies
• collaboration
• regulatory science

Mentioned in this episode

Organizations: SPECCRO

More episodes of The Healthy Enterprise

• The Broken Pipeline: Rethinking Drug Development · July 15, 2026 · 47 min

Explore listener stats, chart rankings, contacts and more on the The Healthy Enterprise podcast page.